Indinavir: Difference between revisions
From Proteopedia
Jump to navigationJump to search
David Canner (talk | contribs) No edit summary |
David Canner (talk | contribs) No edit summary |
||
| Line 49: | Line 49: | ||
! Darunavir | ! Darunavir | ||
! Atazanavir | ! Atazanavir | ||
! | ! 4381 | ||
|- | |- | ||
! [[Pharmaceutical_Drugs#Bioavailability_.28F.29|Bioavailability]] (%) | ! [[Pharmaceutical_Drugs#Bioavailability_.28F.29|Bioavailability]] (%) | ||
| Line 85: | Line 85: | ||
! Darunavir | ! Darunavir | ||
! Atazanavir | ! Atazanavir | ||
! | ! 3.3 | ||
|- | |- | ||
! [[Pharmaceutical_Drugs#Area_Under_the_Curve_.28AUC.29|AUC]] (ng/ml/hr) | ! [[Pharmaceutical_Drugs#Area_Under_the_Curve_.28AUC.29|AUC]] (ng/ml/hr) | ||
| Line 97: | Line 97: | ||
! Darunavir | ! Darunavir | ||
! Atazanavir | ! Atazanavir | ||
! | ! 27000 | ||
|- | |- | ||
! [[Pharmaceutical_Drugs#Inhibitory_Concentration_.28IC50.29|IC<sub>50</sub>]] (nM) | ! [[Pharmaceutical_Drugs#Inhibitory_Concentration_.28IC50.29|IC<sub>50</sub>]] (nM) | ||
| Line 141: | Line 141: | ||
! Hepatic (CYP3A4) | ! Hepatic (CYP3A4) | ||
! Amprenavir | ! Amprenavir | ||
! | ! Hepatic (CYP3A4) | ||
! Lopinavir | ! Lopinavir | ||
! Darunavir | ! Darunavir | ||